Legend Biotech (LEGN) Gross Margin Growth (1y) (2023 - 2026)

Legend Biotech (LEGN) Gross Margin Growth (1y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 372.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -5.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -165.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 236.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Legend Biotech 8.69 Bn 7.79 Bn 129.70 Mn -2,185.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,185.00
Sep 30, 2025 -881.00
Jun 30, 2025 -1,288.00
Mar 31, 2025 1,660.00
Dec 31, 2024 -3,717.00
Sep 30, 2024 1,251.00
Jun 30, 2024 2,024.00
Mar 31, 2024 4,577.00
Dec 31, 2023 8,306.00
Sep 30, 2023 4,777.00